Epi-Cyclophellitol cyclosulfate, a mechanism-based endoplasmic reticulum α-Glucosidase II inhibitor, blocks replication of SARS-CoV-2 and other coronaviruses

Author(s):
Thaler, M.; Ofman, T.P. (0000-0002-1687-2191); Kok, K.; Heming, J.J.A.; Moran, E.; Pickles, I.; Leijs, A.A.; Nieuwendijk, A.M.C.H. van den; Berg, R.J.B.H.N. van den (0000-0002-8585-3904); Ruijgrok, G. (0000-0001-9032-4970); Armstrong, Z.W.B. (0000-0002-4086-2946); Salgado-Benvindo, C.; Ninaber, D.K.; Snijder, E.J.; Boeckel, C.A.A. van (0000-0002-1576-9598); Artola Perez de Azanza, M.E. (0000-0002-3051-3902); Davies, G.J.; Overkleeft, H.S. (0000-0001-6992-4760); Hemert, M.J. van
Published
2024
Publication type
Article / Letter to editor
Date issued
2024-07-25
Language
English
Is part of
ACS Central Science (2024), Vol. 10, no. 8, p. 1594-1608
hdl
1887/4175677
doi
10.1021/acscentsci.4c00506